Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NexGel Inc (NXGL)
NASDAQ:NXGL
NexGel Inc (NXGL) Stock Price & Analysis
21 Followers
NXGL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.46 - $3.15
Previous Close$3.14
Volume313.57K
Average Volume (3M)32.46K
Market Cap
$27.67M
Enterprise Value$28.10M
Total Cash (Recent Filing)$2.40M
Total Debt (Recent Filing)$2.41M
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Aug 07, 2024EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.55
Shares Outstanding6,227,624
10 Day Avg. Volume13,683
30 Day Avg. Volume32,456
Standard Deviation0.16
R-Squared0.07
Alpha-0.00004
Financial Highlights & Ratios
Price to Book (P/B)4.13
Price to Sales (P/S)12.39
Price to Cash Flow (P/CF)-5.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.80
Enterprise Value/Gross Profit45.39
Enterprise Value/Ebitda-9.41
Forecast
1Y Price Target
$6.00Price Target Upside91.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
NexGel Inc News
Bulls Say, Bears Say
Bulls Say
Acquisition BenefitsNexGel can leverage its distribution capabilities to accelerate sales and profitability of Silly George’s products.
New Product LaunchNexGel announced that the first over-the-counter (OTC) product to be launched in North America under its partnership with STADA Arzneimittel AG will be Histasolv, sold as DAOSIN in Europe.
Strategic PartnershipsNexGel announced its subsidiary 'CG Converting and Packaging' signed a supply distribution agreement with Cintas Corporation for its SilverSeal wound and burn care products.
Bears Say
Analyst DowngradeAnalyst lowers the 12-month price target to $6.00 from $7.00 due to delayed product launches and revised revenue estimates.
Product DevelopmentThe company's existing amblyopia patch is progressing slower than expected, adding to concerns about near-term growth.
Product Launch DelaysNexGel announced delays in the launch of AbbVie's RESONIC device and a potential delay in Haleon's product launch, impacting the stock negatively.
---
Ownership Overview
23.43% Insiders
0.89% Mutual Funds
0.65% Other Institutional Investors
75.03% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NXGL FAQ
What was NexGel Inc’s price range in the past 12 months?
NexGel Inc lowest stock price was $1.46 and its highest was $3.15 in the past 12 months.
What is NexGel Inc’s market cap?
Currently, no data Available
When is NexGel Inc’s upcoming earnings report date?
NexGel Inc’s upcoming earnings report date is Aug 07, 2024 which is in 10 days.
How were NexGel Inc’s earnings last quarter?
Currently, no data Available
Is NexGel Inc overvalued?
According to Wall Street analysts NexGel Inc’s price is currently Undervalued.
Does NexGel Inc pay dividends?
NexGel Inc does not currently pay dividends.
What is NexGel Inc’s EPS estimate?
NexGel Inc’s EPS estimate is -$0.14.
How many shares outstanding does NexGel Inc have?
NexGel Inc has 6,227,624 shares outstanding.
What happened to NexGel Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NexGel Inc?
Currently, no hedge funds are holding shares in NXGL
---
NexGel Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (91.08% Upside)
$6.00 (91.08% Upside)
Blogger Sentiment
Bullish
NXGL Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.71%
12-Months-Change
Fundamentals
Return on Equity
-54.94%
Trailing 12-Months
Asset Growth
-5.64%
Trailing 12-Months
Company Description
NexGel Inc
NexGel Inc is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics.
---
NXGL Stock 12 Month Forecast
Average Price Target
$6.00
▲(91.08% Upside)
Technical Analysis
Best Analysts Covering NXGL
1 Year
1 Year Success Rate
13/17 ratings generated profit
1 Year Average Return
+35.51%
reiterated a buy rating 19 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +35.51% per trade.
---